EPIC-Norfolk Publications Database

Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility.

Vergeer M, Boekholdt SM, Sandhu MS, Ricketts SL, Wareham NJ, Brown MJ, de Faire U, Leander K, Gigante B, Kavousi M, Hofman A, Uitterlinden AG, van Duijn CM, Witteman JC, Jukema JW, Schadt EE, van der Schoot E, Kastelein JJ, Khaw KT, Dullaart RP, van Tol A, Trip MD, and Dallinga-Thie GM

Circulation. Jul 2010

(DOI : 10.1161/CIRCULATIONAHA.109.912519)

Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT.

Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, Wareham NJ, Kastelein JJ, Khaw KT, Kamphuisen PW, and Dallinga-Thie GM

Atherosclerosis. Sep 2009

(DOI : 10.1016/j.atherosclerosis.2010.04.004)

Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study.

Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ, Kastelein JJ, Khaw KT, and Boekholdt SM

Journal of lipid research. Aug 2009

(DOI : 10.1194/P900038-JLR200)

Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.

Birjmohun RS, Vergeer M, Stroes ES, Sandhu MS, Ricketts SL, Tanck MW, Wareham NJ, Jukema JW, Kastelein JJ, Khaw KT, and Boekholdt SM

PLoS ONE. May 2009

(DOI : 10.1371/journal.pone.0006809)